For my mother who has had diabetes for 18 years, thyroid problems, kidney disease, and an inflammatory condition called sarcoidosis, is Ondero or Vinglyn a better and safer option after her doctor stopped Eurepa and switched her from Ondero to Vinglyn due to cost?
Both Ondero (linagliptin) and Vinglyn (vildagliptin) are effective, but they handle kidney disease differently. Ondero is very safe for kidneys as it doesn't require dose adjustments. Vinglyn is a great, cost-effective alternative, but its dose must be carefully adjusted based on her kidney function. Since her doctor made this switch, they have likely prescribed a modified dose of Vinglyn to keep her safe. Both options can be used safely, so please keep her doctor updated on her kidney health.